Additional treatment strategies for hypothyroidism: a network meta-analysis
Endocrine Connections · 01.04.2026 · 15 (4)
DOI: 10.1530/ec-26-0011 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endocrine Connections, online erschienen am 13.03.2026. Verfasst von Xingang Lv und 3 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Hypothyroidism often impairs quality of life (QoL). This network meta-analysis (NMA) evaluated the efficacy and safety of additional interventions alongside levothyroxine (LT4).
Methods
This study adhered to the PRISMA guidelines and is registered on PROSPERO (CRD420251085765). PubMed, Embase, Cochrane Library, and Web of Science databases were systematically searched for randomized controlled trials (RCTs) on the treatment of hypothyroidism. A Bayesian NMA was performed, reporting standardized mean differences (SMDs) or risk ratios (RRs) with 95% credible intervals (CrIs). Evidence certainty was assessed using the CINeMA framework.
Results
Thirty-five RCTs involving 3,508 patients were included. Compared with placebo, levothyroxine (LT4) + aerobic training (AT) + resistance training (RT) significantly reduced thyroid-stimulating hormone (TSH) levels (SMD = −3.97, 95% CrI: −5.76, −2.18, CINeMA: high certainty); LT4 + zinc (Zn) + magnesium (Mg) + vitamin A (VA) raised free thyroxine (FT4) (SMD = 1.95, 95% CrI: 1.37, 2.53, CINeMA: high certainty); and LT4 + Zn increased free triiodothyronine (FT3) (SMD = 1.46, 95% CrI: 0.40, 2.51, CINeMA: low certainty). In addition, LT4 + AT + RT significantly improved QoL score (SMD = 1.62, 95% CrI: 0.78, 2.46) and mental health score (MHS) (SMD = 2.1, 95% CrI: 1.19, 3.01, CINeMA: low certainty) compared with LT4 alone. LT4 + RT significantly improved physical function score (SMD = 1.59, 95% CrI: 0.76, 2.43). Liothyronine (LT3) increased adverse events versus placebo (RR = 15.54, 95% CrI: 2.68, 501.14, CINeMA: very low certainty).
Conclusion
The combination of LT4, AT, and RT may be the preferred strategy for reducing TSH, enhancing QoL, and improving MHS. Clinical interventions should be tailored based on individual patient profiles.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
- First Clinical Medical College, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Second Department of Endocrinology, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
ORCID-Profile: Likun Du
Zitieren
APA
Lv, X., Qin, W., Li, J., & Du, L. (2026). Additional treatment strategies for hypothyroidism: a network meta-analysis. Endocrine Connections, 15(4). https://doi.org/10.1530/ec-26-0011
Vancouver
Lv X, Qin W, Li J, Du L. Additional treatment strategies for hypothyroidism: a network meta-analysis. Endocrine Connections. 2026;15(4). doi:10.1530/ec-26-0011
BibTeX
@article{Lv2026,
author = {Lv, Xingang and Qin, Wentao and Li, Jiarui and Du, Likun},
title = {Additional treatment strategies for hypothyroidism: a network meta-analysis},
journal = {Endocrine Connections},
year = {2026},
volume = {15},
number = {4},
doi = {10.1530/ec-26-0011}
}
EUVIMED